Literature DB >> 10415157

Activated astrocytes display increased 5-HT2a receptor expression in pathological states.

C Wu1, S K Singh, P Dias, S Kumar, D M Mann.   

Abstract

In human brain tissues from patients dying with cerebral infarction, hypertensive encephalopathy, Alzheimer's disease, Huntington's disease, frontotemporal dementia, and Creutzfeldt-Jakob disease there is an activation of astrocytes. Such activated astrocytes display GFAP and strong 5-HT(2A), but not 5-HT(2B) or 5-HT(2C), receptor immunoreactivity; this 5-HT(2A) reaction has not been observed in normal, nonactivated astrocytes. It is suggested that an up-regulation of 5-HT(2A) receptors may be part of an early response reaction in astrocytes, possibly designed to maintain homeostasis or to induce secondary message pathways involving trophic factors or glycogenolysis. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10415157     DOI: 10.1006/exnr.1999.7105

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  13 in total

1.  Exposure to serotonin adversely affects oligodendrocyte development and myelination in vitro.

Authors:  Lir-Wan Fan; Abhay Bhatt; Lu-Tai Tien; Baoying Zheng; Kimberly L Simpson; Rick C S Lin; Zhengwei Cai; Praveen Kumar; Yi Pang
Journal:  J Neurochem       Date:  2015-01-28       Impact factor: 5.372

Review 2.  Psychedelic-inspired approaches for treating neurodegenerative disorders.

Authors:  Hannah N Saeger; David E Olson
Journal:  J Neurochem       Date:  2021-12-05       Impact factor: 5.546

3.  Astroglial Serotonin Receptors as the Central Target of Classic Antidepressants.

Authors:  Alexei Verkhratsky; Vladimir Parpura; Caterina Scuderi; Baoman Li
Journal:  Adv Neurobiol       Date:  2021

4.  Serotonin2A receptor binding potential in people with aggressive and violent behaviour.

Authors:  Jeffrey H Meyer; Alan A Wilson; Pablo Rusjan; Michael Clark; Sylvain Houle; Scott Woodside; John Arrowood; Krystle Martin; Michael Colleton
Journal:  J Psychiatry Neurosci       Date:  2008-11       Impact factor: 6.186

Review 5.  Gliogenesis and glial pathology in depression.

Authors:  G Rajkowska; J J Miguel-Hidalgo
Journal:  CNS Neurol Disord Drug Targets       Date:  2007-06       Impact factor: 4.388

Review 6.  Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue.

Authors:  Grazyna Rajkowska; Craig A Stockmeier
Journal:  Curr Drug Targets       Date:  2013-10       Impact factor: 3.465

7.  Preferential modulation of the lateral habenula activity by serotonin-2A rather than -2C receptors: Electrophysiological and neuroanatomical evidence.

Authors:  Francis Delicata; Cristiano Bombardi; Massimo Pierucci; Roberto Di Maio; Philippe De Deurwaerdère; Giuseppe Di Giovanni
Journal:  CNS Neurosci Ther       Date:  2018-02-25       Impact factor: 5.243

8.  Serotonin 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer and normal aging patients.

Authors:  Dietrich E Lorke; Gang Lu; Eric Cho; David T Yew
Journal:  BMC Neurosci       Date:  2006-04-27       Impact factor: 3.288

9.  A Model of Post-Infection Fatigue Is Associated with Increased TNF and 5-HT2A Receptor Expression in Mice.

Authors:  Yvonne Couch; Qin Xie; Louise Lundberg; Trevor Sharp; Daniel C Anthony
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

10.  Different serotonergic expression in nevomelanocytic tumors.

Authors:  Clara Naimi-Akbar; Markus Ritter; Sasika Demel; Husameldin El-Nour; Mari-Anne Hedblad; Efrain C Azmitia; Klas Nordlind
Journal:  Cancers (Basel)       Date:  2010-06-07       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.